![](https://www.scientistlive.com/sites/scientistlive/files/20160217_CDC_A_001.jpg)
Lymphoma drug recommended for EU approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorisation of biotechnology company Regeneron Pharmaceuticals' product Odronextamab to …